Page last updated: 2024-10-20

pyridoxine and Hyperlipoproteinemia Type II

pyridoxine has been researched along with Hyperlipoproteinemia Type II in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, J1
Yancey, PG1
Tao, H1
Borja, MS1
Smith, LE1
Kon, V1
Davies, SS1
Linton, MF1

Other Studies

1 other study available for pyridoxine and Hyperlipoproteinemia Type II

ArticleYear
Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
    Nutrients, 2020, Jun-30, Volume: 12, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Aryldialkylphosphatase; ATP Binding Cassette

2020